Literature DB >> 27017587

Placebo and its evil twin, nocebo.

Michael Glick.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27017587     DOI： 10.1016/j.adaj.2016.02.009

Source DB:  PubMed          Journal:  J Am Dent Assoc        ISSN： 0002-8177            Impact factor:   3.634


× No keyword cloud information.
  3 in total

1.  Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan.

Authors:  David Kudrow; John H Krege; Hans P Hundemer; Paul H Berg; Rashna Khanna; Michael H Ossipov; Patricia Pozo-Rosich
Journal:  Headache       Date:  2020-01-13       Impact factor: 5.887

2.  Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing.

Authors:  L S Kaertner; M B Steinborn; H Kettner; M J Spriggs; L Roseman; T Buchborn; M Balaet; C Timmermann; D Erritzoe; R L Carhart-Harris
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

Review 3.  What is the nocebo effect and does it apply to dentistry?-A narrative review.

Authors:  Takeshi Watanabe; Mette Sieg; Sigrid Juhl Lunde; Pankaj Taneja; Lene Baad-Hansen; Maria Pigg; Lene Vase
Journal:  J Oral Rehabil       Date:  2022-03-09       Impact factor: 3.558
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.